Menu
close
Please contact us for more information or to learn if you are eligible to participate.
To demonstrate the safety and effectiveness of BioTraceIO Lite in estimating the area of primary and secondary tissue damage post-procedure in radiofrequency (RF) and microwave (MW) liver tissue ablation procedures
Principal Investigator | Dr. Mario Moya |
Co-PI | Edgar Lopez Pacheco |
Sponsor | Techsomed |
Type of Trial | Interventional |